IL15 and neoplasm: Consistent with this hypothesis, our CAR-T cell survival analysis indicated that FAP/IL-15 CAR-T cells persisted for over four weeks in the spleen, peripheral blood (coinciding with an increased TSCM proportion), and tumor tissues, surpassing other groups, including FAP CAR-T cells without IL-15 secretion.